Join the Class Action Against Indivior PLC (INDV) Now
Important Notice for Indivior Investors
Levi & Korsinsky, LLP issues a call to investors of Indivior PLC (NASDAQ: INDV). They are notifying eligible investors about a class action securities lawsuit, aiming to recover losses incurred due to alleged fraudulent actions by the company.
Understanding the Class Action
CLASS DEFINITION: This lawsuit is intended for individuals who experienced financial damage as a result of the alleged fraudulent activities involving Indivior. The timeline for this lawsuit spans from February 22, 2024 to July 8, 2024. Interested parties should follow the link provided for detailed information and to express their interest in joining the lawsuit.
Contact Information
Investors with questions can reach out directly to Joseph E. Levi, Esq. via email at [email protected] or by calling (212) 363-7500.
Details of the Case
CASE DETAILS: The issued complaint alleges that defendants knowingly misled investors regarding the company's financial projections and the impact of legislative changes on Indivior's products. Key allegations include:
1. Misrepresentation of Financial Forecasts
The company is accused of grossly overstating its forecasting ability which misled investors regarding the financial impact of new legislation.
2. Overstatement of Product Prospects
Defendants are also said to have exaggerated the potential market success of Indivior's treatments such as SUBLOCADE, PERSERIS, and OPVEE.
3. Inaccurate Revenue Predictions
It is alleged that Indivior was unlikely to meet its revenue guidance due to legislative actions, information concealed by the defendants.
4. Risk of Service Cessation
The lawsuit contends that Indivior was at considerable risk of ceasing sales and marketing activities for some of its products but failed to disclose this risk.
Next Steps for Affected Investors
WHAT'S NEXT? If you incurred losses during the specified period, note that you have until October 1, 2024 to request the court to appoint you as a lead plaintiff. Remember, to receive compensation, you do not need to be a lead plaintiff.
No Upfront Costs for Participants
NO COST TO YOU: If you qualify as a class member, you may receive compensation without needing to pay any fees upfront. There are no hidden costs or obligations to participate.
Why Trust Levi & Korsinsky
WHY LEVI & KORSINSKY: With a rich history of securing hundreds of millions for investors, Levi & Korsinsky has built a strong reputation over two decades. The firm is recognized for its expertise in complex securities litigation, consistently ranking among the top firms in the field.
Contact Levi & Korsinsky
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com
Frequently Asked Questions
1. What is the class action about?
This class action is aimed at recovering losses for investors who were misled by false statements made by Indivior regarding its financial performance.
2. Who can participate in this class action?
Any investor who suffered losses in Indivior PLC between the specified dates can participate in this class action.
3. What is the deadline to join the class action?
The deadline to request to join as a lead plaintiff is October 1, 2024.
4. Will I have to pay any costs to join?
No, there are no costs or obligations to participate in this class action for class members.
5. How can I contact Levi & Korsinsky for more information?
You can reach out to them via email or phone. Contact Joseph E. Levi, Esq. via the provided email address or at (212) 363-7500 for assistance.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Related Articles
- Keros Therapeutics Progresses in Phase 2 TROPOS Trial for PAH
- Protara Therapeutics to Showcase Innovations at H.C. Wainwright Conference
- The Chefs' Warehouse Engages in CL King's Best Ideas Conference
- LAVA Therapeutics Prepares for H.C. Wainwright Conference 2024
- Compass Therapeutics Engages Investors at Upcoming Events
- Denali Therapeutics Plans Accelerated Approval for DNL310
- Pasithea Therapeutics Welcomes Dr. Rebecca Brown to Advisory Board
- Bicara Therapeutics Pursues IPO for Innovative Cancer Treatments
- Illumina's Legal Win Against EU Sets New Merger Precedents
- The Cancer & Hematology Centers Unveils New Clinic in Grand Rapids
- Forward Therapeutics Appoints Ulrich Thienel as CMO
- Earnings Reports Tuesday: Zscaler, Gitlab, Healthequity Insights
- Mercer Advisors Expands Northeast Presence with Benchmark Wealth Management
- Kevin Guest's Insights on the Power of Entrepreneurs Today
- NRx Pharmaceuticals and HOPE Therapeutics to Present at Conference
- Alliance Trust PLC Announces Latest Net Asset Value Updates
- Is Norwegian or Carnival Cruise Line Stock the Better Buy?
- Amicus Therapeutics to Showcase at Investor Conferences This Fall
- Opthea's Upcoming Presentations at Investment Conferences
- Abeona Therapeutics Engages Investors at Upcoming Conferences
- PharmaCorp Strengthens Position with New Pharmacy Acquisition
- Cognition Therapeutics: Upcoming Investor Conferences Insights
- MiNK Therapeutics to Showcase Innovations at Global Conference
- Calliditas Therapeutics AB Extraordinary Meeting Announcement
- Soligenix Secures European Patent for Synthetic Hypericin Production
Recent Articles
- Senti Bio Hosts Key Investor Conferences This Fall
- Aspire Biopharma and PowerUp Combine to Innovate Drug Delivery
- Cathay Pacific Inspects Fleet: 15 A350s Require Repairs
- Orion Energy Systems to Showcase at H.C. Wainwright Event
- ATHA Energy's 2024 Exploration Uncovers New Mineral Trends
- ADC Therapeutics Announces Conference Presentations in September
- Eyenovia Appoints Andrew Jones as Chief Financial Officer
- Evolution Space Celebrates Successful Sea Launch of Hypersonic Rocket
- Dyne Therapeutics Strengthens Leadership for Growth Ahead
- REMSleep Secures Patent Approval for Nasal Ventilation System
- Join the Class Action Against Lululemon Athletica Inc. Today
- Kenneth M. Overgaard-Nielsen Joins Computop Management Board
- Clearlake Capital Expands Global Private Credit with MV Credit Acquisition
- Esports World Cup Foundation Partners with Media Groups
- Jefferies Upgrades Azelis and IMCD with Positive Market Outlook
- Anticipation Rises as Jobs Report Approaches Market Challenges
- Aidoc Expands AI Solutions to Enhance Healthcare in Europe
- Scania Unveils Next-Gen 13-Litre Marine Engine for Sustainability
- B2C2 Appoints Cactus Raazi as New US Chief Executive Officer
- Nordea Invest Announces Acontoudlodning for 2024 Period
- Empowering Women Entrepreneurs: Operation HOPE Launches Program
- Lingerfelt Secures 233,359 Sq. Ft. Lease with VRC
- Exploring the Growth of Blockchain in Healthcare to $90.52 Billion
- Exploring Japan's Lessons for the Future of the US Economy
- Smart Infrastructure Market Estimated to Reach $2.04 Trillion